SLXP Volume Alert - SLXP 91.47 Salix Pharmaceuticals $SLXP

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
SLXP Volume Alert - SLXP 91.47 Salix Pharmaceuticals $SLXP Hit a high of 96.00 Currently 11/07/14 Last price 91.47 -47.08 -33.98% With a day low of 86.00 and a current volume of 25,841,400.

SLXP Salix Pharmaceuticals Recent Headline News

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.32 (+0.03), YHOO: 48.55 (+0.62), MNST: 108.39 (+7.91), ANF: 29.50 (-5.88), SLXP: 91.47 (-47.08), FFIV: 126.66 (+1.45), AKS: 6.62 (+0.48), TWTR: 40.31 (-0.53), GDX: 18.64 (+1.43), FXF: 101.10 (+0.79)

Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP)
GlobeNewswire - Fri Nov 07, 10:12PM CST
Labaton Sucharow LLP ("Labaton Sucharow" filed a securities class action lawsuit on behalf of Woburn Retirement System in the U.S. District Court for the Southern District of New York. The lawsuit was filed on behalf of all persons or entities who, between November 8, 2013 and November 6, 2014, inclusive (the "Class Period", purchased or otherwise acquired the securities of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP).
SLXP: 91.47 (-47.08)

SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - Fri Nov 07, 9:00PM CST
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF", announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).
SLXP: 91.47 (-47.08)

Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 7:10PM CST
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders.
SLXP: 91.47 (-47.08)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.43 (-0.17), LCI: 50.17 (-0.82), AKRX: 36.59 (-1.29), AFSI: 49.89 (-0.58), EXPE: 85.11 (+1.05), FFIV: 126.66 (+1.45), SLXP: 91.47 (-47.08), MPWR: 44.69 (-0.13), TMH: 54.14 (-2.70), ATHM: 43.63 (-1.60)

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.24 (-0.12), PRSC: 38.48 (-0.90), FNGN: 31.39 (-9.43), LACO: 6.91 (-1.23), MSON: 11.80 (-2.44), SLXP: 91.47 (-47.08), FNHC: 26.14 (+0.04), MDRX: 11.54 (-2.01), PCMI: 7.45 (-3.15), UBNT: 28.78 (-5.84), PFMT: 7.04 (-1.61), ICPT: 172.59 (-74.39), ANDE: 54.79 (+2.83), ACTA: 16.52 (+0.62)

Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" for possible violations of federal securities laws.
SLXP: 91.47 (-47.08)

Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)

Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 196.00 (-1.40), VRX: 126.11 (-2.66), DVA: 74.49 (-3.54), GILD: 106.45 (-0.49), SLXP: 91.47 (-47.08), ICPT: 172.59 (-74.39), HUM: 130.58 (-9.29)

Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 91.47 (-47.08)

Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FSLR: 50.29 (-6.12), RIG: 29.71 (-0.21), WWWW: 15.40 (+0.68), GNRC: 40.86 (-1.23), SLXP: 91.47 (-47.08), BRKR: 17.91 (-2.98), KATE: 30.37 (-0.59), GNW: 8.41 (-0.25), SHLD: 42.81 (+10.14), ANR: 2.91 (+0.39), MCO: 98.95 (-0.04), HUM: 130.58 (-9.29)

Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 108.39 (+7.91), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00)

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), AKS: 6.62 (+0.48), SHLD: 42.81 (+10.14), VSAT: 65.39 (+5.13)

Why Salix Pharmaceuticals Ltd. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 07, 2:45PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Salix Pharmaceuticals , a biopharmaceutical company...
SLXP: 91.47 (-47.08)

SHAREHOLDER ALERT: Investigation on Behalf of Salix Pharmaceuticals, Ltd. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Fri Nov 07, 2:32PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (NASDAQ:SLXP). The investigation concerns possible violations of federal securities laws and focuses on certain statements issued by Salix concerning the Company's financial results, operations and business prospects. Salix is engaged in the acquisition, development and commercialization of prescription drugs and medical devices in the United States to treat gastrointestinal diseases.
SLXP: 91.47 (-47.08)

Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour
at The Street - Fri Nov 07, 2:19PM CST
U.S. stocks slip on Friday afternoon, though with only slight moves, as Wall Street overlooks a mixed October jobs report to digest the big picture of a tightening labor market.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP
Business Wire - Fri Nov 07, 2:10PM CST
The Rosen Law Firm announces that it is investigating potential securities claims against Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) resulting from allegations that the Company may have issued materially misleading business information to the investing public.
SLXP: 91.47 (-47.08)

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Salix Pharmaceuticals, Ltd.
Business Wire - Fri Nov 07, 1:02PM CST
Levi & Korsinsky, LLP is investigating Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP) in connection with possible violations of federal securities laws by the Board of Directors of the Company.
SLXP: 91.47 (-47.08)

Most active Nasdaq-traded stocks
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
WFM: 46.81 (+1.96), FB: 75.60 (+0.34), SLXP: 91.47 (-47.08), ZNGA: 2.43 (+0.07), MSFT: 48.68 (-0.02), INTC: 33.58 (-0.24), AAPL: 109.01 (+0.31), CSCO: 25.33 (+0.07)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating the Pioneers: Results of the 2025 Belonging Awards

Updated Category News Views 242

Introduction to the 2025 Belonging Awards The 2025 Belonging Awards stand as a testament to organizations dedicated to fostering an inclusive workplace. This year, the awards, organized by the Employer Branding Institute, saw a remarkable competition among companies globally, showcasing their commitment to Diversity, Equity, and Inclusion (DEI). The extensive evaluation...

Continue Reading
AI Innovations Driving Growth in Hypothyroidism Market

Updated Category News Views 183

The Growing Hypothyroidism Market and Its Innovations The global hypothyroidism market is on the brink of significant expansion, with projections indicating a remarkable growth of USD 789.8 million over the upcoming years. This growth is fueled by innovative advancements and strategic approaches within the healthcare sector. The market is expected to exhibit an impressive...

Continue Reading
Richmond Heights Celebrates 75 Years with Inspiring Stories

Updated Category News Views 273

Celebating 75 Years of Richmond Heights The Richmond Heights community recently came together for a significant milestone, marking 75 years of rich history and cultural diversity. The celebration was not only about the past; it was a heartfelt acknowledgment of the leaders who have molded this extraordinary place over decades. A Tribute to Community Leaders This special...

Continue Reading
Investigation Launched into Dyne Therapeutics Over Stock Drop

Updated Category News Views 82

Investigation Launched into Dyne Therapeutics Following Stock Decline Dyne Therapeutics, Inc. (NASDAQ: DYN), recognized for its groundbreaking approaches to treating muscular dystrophy, is currently facing scrutiny as Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims on behalf of investors. This action follows some concerning news...

Continue Reading
Taseko Mines: Highlights from Q1 Earnings Report and Future Plans

Updated Category News Views 211

Insight into Taseko Mines Limited's Q1 2025 Performance Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO), based in Vancouver, British Columbia, is making waves in the mining sector with its compelling first quarter earnings report for 2025. The company disclosed an Adjusted EBITDA of $34 million and earnings from mining operations before depletion and...

Continue Reading